COVID-19 and liver cancer clinical trials: Not everything is lost

Liver Int. 2020 Jul;40(7):1541-1544. doi: 10.1111/liv.14532.

Antonio D'Alessio¹, Nicola Personeni^{1

2}, Tiziana Pressiani¹, Silvia Bozzarelli¹, Valeria Smiroldo¹, Matteo Simonelli^{1

2}, Ana Lleo^{2

3}, Armando Santoro^{1

2}, Lorenza Rimassa^{1

2}

¹ Medical Oncology and Hematology Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center-IRCCS, Rozzano (Milan), Italy.
² Department of Biomedical Sciences, Humanitas University, Pieve Emanuele (Milan), Italy.
³ Division of Internal Medicine and Hepatology, Humanitas Clinical and Research Center-IRCCS, Rozzano (Milan), Italy.

No abstract available

Keywords: BTC; COVID-19; HCC; SARS-CoV-2; clinical trials; liver cancer.

Publication types